AIRE vs IMMX Comparison

ReAlpha Tech Corp is an early-stage company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It offers retail investors the opportunity to participate in short-term rental properties it will acquire by offering interest in each property portfolio. Its revenues consist of short-term rental revenues from the rental of its properties via Airbnb and such digital hospitality platforms. The company has two segments (i) platform services and (ii) rental business. The company generates the majority of its revenue from the Platform services segment.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.